Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ACCENDRA HEALTH INC/VA/ (ACH)

Accendra Health extends $150 million receivables sale program to October 2029

Neutral Impact 2 of 5 financing Written later

Accendra Health's subsidiaries amended their receivables purchase agreement with PNC Bank, extending the scheduled termination date to October 2029. The $150 million program size is unchanged, and the company says the extension supports its liquidity. The filing does not disclose financial results or a cost of the amendment.

Key points

  • Third Amendment to the receivables purchase agreement was signed October 29, 2026
  • Scheduled Termination Date extended to October 2029; $150 million facility size unchanged
  • Revised account control provisions and reporting obligations; PNC Bank is administrative agent
  • Full amendment to be filed as an exhibit to the 2026 Form 10-K

The filing

CompanyACCENDRA HEALTH INC/VA/ (ACH)
Form8-K, current report
Filed with the SECNov 2, 2026, 6:50 AM ET
Accession number0001104659-26-120905

Items reported: 1.01 Material Definitive Agreement7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.